The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 23, 2018
Filed:
Dec. 18, 2015
Applicant:
Wellesley Pharmaceuticals, Llc, Newtown, PA (US);
Inventor:
David A. Dill, Newtown, PA (US);
Assignee:
WELLESLEY PHARMACEUTICALS, LLC, Newtown, PA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/167 (2006.01); A61K 45/06 (2006.01); A61K 31/7088 (2006.01); A61K 31/44 (2006.01); A61K 39/395 (2006.01); A61K 31/192 (2006.01); A61K 31/27 (2006.01); A61K 31/437 (2006.01); A61K 31/616 (2006.01); A61K 31/122 (2006.01); A61K 31/405 (2006.01);
U.S. Cl.
CPC ...
A61K 31/167 (2013.01); A61K 31/122 (2013.01); A61K 31/192 (2013.01); A61K 31/27 (2013.01); A61K 31/405 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/616 (2013.01); A61K 31/7088 (2013.01); A61K 45/06 (2013.01);
Abstract
Pharmaceutical compositions for reducing frequency of urination are disclosed. The pharmaceutical compositions comprise one or more prostaglandin pathway inhibitors and a pharmaceutically acceptable carrier. Also disclosed are methods of making and using the pharmaceutical compositions.
Dill, David. (2018). Composition for reducing frequency of urination, method of making and use thereof (U.S. Patent No. 10105328). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10105328
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile